PhosImmune

PhosImmune is a immunotherapy co. developing cancer vaccines using its platform technology of over 400 unique phosphopeptide tumor antigens

  • Stage Product In Development
  • Industry Biotechnology
  • Location Washington, D.C., DC, USA
  • Currency USD

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free